Federal Circuit Axes Drug Patent For Inequitable Conduct
Attorneys for Dutch drug manufacturer Ferring B.V. misled patent examiners while securing a diabetes treatment patent, according to a ruling Wednesday from the U.S. Court of Appeals for the Federal Circuit...To view the full article, register now.
Already a subscriber? Click here to view full article